• The global Naltrexone Hydrochloride market was valued at USD 20 million in 2023 and is expected to reach USD 26.79 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.30% over the forecast period.
• The North American market alone accounted for USD 5.51 million in 2023 and is projected to grow at a CAGR of 2.83% during the same period. The market expansion is primarily driven by increasing cases of substance abuse, rising awareness about addiction treatments, and government initiatives to curb opioid misuse.
Email: help@24marketreports.com
• Naltrexone Hydrochloride (HCL) is an opioid receptor antagonist widely used in the treatment of alcohol and opioid dependence. It works by blocking the euphoric and sedative effects of opioids, reducing the cravings and dependency associated with these substances. As a crucial component in addiction treatment programs, Naltrexone HCL is available in oral and extended-release injectable forms.
Email: help@24marketreports.com +1(917)-997-2424
